Genetic Breakthroughs in Cancer Treatment: FDA-Approved Therapies and Personalized Medicine
During her budget speech, Finance Minister Nirmala Sitharaman announced the exemption of customs duty on three cancer medications: Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. Notably, Trastuzumab Deruxtecan targets HER2-positive cancers, highlighting...